BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12889565)

  • 1. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
    Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
    Scand J Gastroenterol; 2003 Jul; 38(7):770-8. PubMed ID: 12889565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
    Tsai WL; Cheng JS; Lai KH; Lin CP; Lo GH; Hsu PI; Yu HC; Lin CK; Chan HH; Chen WC; Chen TA; Li WL; Liang HL
    Aliment Pharmacol Ther; 2008 Aug; 28(3):304-11. PubMed ID: 19086330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
    Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
    Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Schoppmeyer K; Weis S; Mössner J; Fleig WE
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K; Yoshioka H; Ito S; Fujiwara K
    Hepatology; 1998 Jan; 27(1):67-72. PubMed ID: 9425919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
    Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
    J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
    Chang YJ; Chen LJ; Chang YJ; Chen PD
    Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
    Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study.
    Huo TI; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Ann Oncol; 2003 Nov; 14(11):1648-53. PubMed ID: 14581273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.
    Giorgio A; Tarantino L; de Stefano G; Perrotta A; Aloisio V; del Viscovo L; Alaia A; Lettieri G
    Eur J Ultrasound; 2000 Dec; 12(2):145-54. PubMed ID: 11118922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
    Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
    Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.
    Fartoux L; Arrive L; Andreani T; Serfaty L; Chazouillères O; Tubiana JM; Poupon R; Rosmorduc O
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1213-9. PubMed ID: 16518274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection.
    Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
    Scand J Gastroenterol; 2004 Feb; 39(2):168-73. PubMed ID: 15000280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
    Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
    Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
    World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.
    Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):325-31. PubMed ID: 15195898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients.
    Livraghi T; Bolondi L; Lazzaroni S; Marin G; Morabito A; Rapaccini GL; Salmi A; Torzilli G
    Cancer; 1992 Feb; 69(4):925-9. PubMed ID: 1310435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.